ProPhase Labs Inc (PRPH)
5.16
+0.55
(+11.93%)
USD |
NASDAQ |
May 01, 16:00
5.15
-0.01
(-0.19%)
After-Hours: 20:00
ProPhase Labs Price to Book Value: 1.882 for May 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 30, 2024 | 1.672 |
| April 29, 2024 | 1.685 |
| April 26, 2024 | 1.721 |
| April 25, 2024 | 1.809 |
| April 24, 2024 | 1.849 |
| April 23, 2024 | 1.886 |
| April 22, 2024 | 1.790 |
| April 19, 2024 | 1.922 |
| April 18, 2024 | 1.988 |
| April 17, 2024 | 2.291 |
| April 16, 2024 | 2.686 |
| April 15, 2024 | 2.249 |
| April 12, 2024 | 2.382 |
| April 11, 2024 | 2.339 |
| April 10, 2024 | 2.24 |
| April 09, 2024 | 2.229 |
| April 08, 2024 | 2.412 |
| April 05, 2024 | 2.485 |
| April 04, 2024 | 2.404 |
| April 03, 2024 | 2.419 |
| April 02, 2024 | 2.518 |
| April 01, 2024 | 2.503 |
| March 28, 2024 | 2.364 |
| March 27, 2024 | 2.288 |
| March 26, 2024 | 2.298 |
| Date | Value |
|---|---|
| March 25, 2024 | 2.266 |
| March 22, 2024 | 2.134 |
| March 21, 2024 | 2.054 |
| March 20, 2024 | 2.021 |
| March 19, 2024 | 1.911 |
| March 18, 2024 | 1.878 |
| March 15, 2024 | 1.842 |
| March 14, 2024 | 1.776 |
| March 13, 2024 | 1.845 |
| March 12, 2024 | 1.754 |
| March 11, 2024 | 1.794 |
| March 08, 2024 | 1.736 |
| March 07, 2024 | 1.725 |
| March 06, 2024 | 1.677 |
| March 05, 2024 | 1.725 |
| March 04, 2024 | 1.684 |
| March 01, 2024 | 1.666 |
| February 29, 2024 | 1.633 |
| February 28, 2024 | 1.732 |
| February 27, 2024 | 1.838 |
| February 26, 2024 | 1.856 |
| February 23, 2024 | 1.812 |
| February 22, 2024 | 1.812 |
| February 21, 2024 | 1.809 |
| February 20, 2024 | 1.809 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.202
Minimum
Sep 05 2023
18.42
Maximum
Jan 15 2021
2.869
Average
1.933
Median
Nov 03 2021
Price to Book Value Benchmarks
| Fonar Corp | 0.6275 |
| XWELL Inc | 0.5566 |
| Applied DNA Sciences Inc | 0.8319 |
| Veracyte Inc | 1.447 |
| OncoCyte Corp | 1.675 |
Price to Book Value Related Metrics
| PS Ratio | 2.035 |
| Price | 5.16 |
| Earnings Yield | -19.03% |
| Market Cap | 92.93M |